메뉴 건너뛰기




Volumn 94, Issue 2, 2009, Pages 428-433

Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; OCTREOTIDE; PASIREOTIDE; PENTETREOTIDE; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5;

EID: 59749106496     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1712     Document Type: Article
Times cited : (37)

References (32)
  • 3
    • 33750986529 scopus 로고    scopus 로고
    • Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects
    • Gola M, Doga M, Bonadonna S, Mazziotti G, Vescovi PP, Giustina A 2006 Neuroendocrine tumors secreting growth hormone-releasing hormone: pathophysiological and clinical aspects. Pituitary 9:221-229
    • (2006) Pituitary , vol.9 , pp. 221-229
    • Gola, M.1    Doga, M.2    Bonadonna, S.3    Mazziotti, G.4    Vescovi, P.P.5    Giustina, A.6
  • 5
    • 0032780823 scopus 로고    scopus 로고
    • Somatostatin and its receptor family
    • Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
    • (1999) Front Neuroendocrinol , vol.20 , pp. 157-198
    • Patel, Y.C.1
  • 6
    • 0029089558 scopus 로고
    • Somatostatin analogs: Clinical application in relation to human somatostatin receptor subtypes
    • Hofland LJ, Visser-Wisselaar HA, Lamberts SW 1995 Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 50:287-297
    • (1995) Biochem Pharmacol , vol.50 , pp. 287-297
    • Hofland, L.J.1    Visser-Wisselaar, H.A.2    Lamberts, S.W.3
  • 8
    • 0032758263 scopus 로고    scopus 로고
    • Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors
    • Kimura N, Pilichowska M, Date F, Kimura I, Schindler M 1999 Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin Cancer Res 5:3483-3487
    • (1999) Clin Cancer Res , vol.5 , pp. 3483-3487
    • Kimura, N.1    Pilichowska, M.2    Date, F.3    Kimura, I.4    Schindler, M.5
  • 10
    • 0036111856 scopus 로고    scopus 로고
    • SOM230: A novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
    • Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G 2002 SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 146:707-716
    • (2002) Eur J Endocrinol , vol.146 , pp. 707-716
    • Bruns, C.1    Lewis, I.2    Briner, U.3    Meno-Tetang, G.4    Weckbecker, G.5
  • 13
    • 0023546629 scopus 로고
    • Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995
    • Oosterom R, Verleun T, Uitterlinden P, Bruining HA, Bruining GJ, Verschoor L, Lamberts SW 1987 Studies on insulin secretion by monolayer cultures of normal and tumorous human pancreatic cells. Effects of glucose, somatostatin and SMS 201-995. J Endocrinol Invest 10:547-552
    • (1987) J Endocrinol Invest , vol.10 , pp. 547-552
    • Oosterom, R.1    Verleun, T.2    Uitterlinden, P.3    Bruining, H.A.4    Bruining, G.J.5    Verschoor, L.6    Lamberts, S.W.7
  • 14
    • 0030832510 scopus 로고    scopus 로고
    • Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome
    • Losa M, von Werder K 1997 Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome. Clin Endocrinol (Oxf) 47:123-135
    • (1997) Clin Endocrinol (Oxf) , vol.47 , pp. 123-135
    • Losa, M.1    von Werder, K.2
  • 15
    • 0024065111 scopus 로고
    • Growth hormone-releasing hormone-producing tumors: Clinical, biochemical, and morphological manifestations
    • Sano T, Asa SL, Kovacs K 1988 Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9:357-373
    • (1988) Endocr Rev , vol.9 , pp. 357-373
    • Sano, T.1    Asa, S.L.2    Kovacs, K.3
  • 16
    • 0346774833 scopus 로고    scopus 로고
    • Acromegaly caused by a growth hormone-releasing hormone-secreting carcinoid tumor: Case report
    • Altstadt TJ, Azzarelli B, Bevering C, Edmondson J, Nelson PB 2002 Acromegaly caused by a growth hormone-releasing hormone-secreting carcinoid tumor: case report. Neurosurgery 50:1356-1359
    • (2002) Neurosurgery , vol.50 , pp. 1356-1359
    • Altstadt, T.J.1    Azzarelli, B.2    Bevering, C.3    Edmondson, J.4    Nelson, P.B.5
  • 17
    • 0028791765 scopus 로고
    • Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: Superiority of continuous versus intermittent administration to control hormonal secretion
    • Lefebvre S, De Paepe L, Abs R, Rahier J, Selvais P, Maiter D 1995 Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion. Eur J Endocrinol 133:320-324
    • (1995) Eur J Endocrinol , vol.133 , pp. 320-324
    • Lefebvre, S.1    De Paepe, L.2    Abs, R.3    Rahier, J.4    Selvais, P.5    Maiter, D.6
  • 18
    • 0033305296 scopus 로고    scopus 로고
    • Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor
    • Van den Bruel A, Fevery J, Van Dorpe J, Hofland L, Bouillon R 1999 Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor. J Clin Endocrinol Metab 84:3162-3169
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 3162-3169
    • Van den Bruel, A.1    Fevery, J.2    Van Dorpe, J.3    Hofland, L.4    Bouillon, R.5
  • 21
    • 0141676019 scopus 로고    scopus 로고
    • Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion
    • Ren SG, Taylor J, Dong J, Yu R, Culler MD, Melmed S 2003 Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. J Clin Endocrinol Metab 88:4239-4245
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 4239-4245
    • Ren, S.G.1    Taylor, J.2    Dong, J.3    Yu, R.4    Culler, M.D.5    Melmed, S.6
  • 22
    • 0038578269 scopus 로고    scopus 로고
    • Zatelli MC, Piccin D, Tagliati F, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Culler MD, degli Uberti EC 2003 Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion. J Clin Endocrinol Metab 88:2797-2802
    • Zatelli MC, Piccin D, Tagliati F, Ambrosio MR, Margutti A, Padovani R, Scanarini M, Culler MD, degli Uberti EC 2003 Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion. J Clin Endocrinol Metab 88:2797-2802
  • 28
    • 15944427116 scopus 로고    scopus 로고
    • Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly
    • Bevan JS 2005 Clinical review: the antitumoral effects of somatostatin analog therapy in acromegaly. J Clin Endocrinol Metab 90:1856-1863
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 1856-1863
    • Bevan, J.S.1
  • 29
    • 33750970585 scopus 로고    scopus 로고
    • Treatment of neuroendocrine tumors with somatostatin analogs
    • Janson ET 2006 Treatment of neuroendocrine tumors with somatostatin analogs. Pituitary 9:249-256
    • (2006) Pituitary , vol.9 , pp. 249-256
    • Janson, E.T.1
  • 30
    • 0023865612 scopus 로고
    • Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995
    • Barkan AL, Shenker Y, Grekin RJ, Vale WW 1988 Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995. Cancer 61:221-226
    • (1988) Cancer , vol.61 , pp. 221-226
    • Barkan, A.L.1    Shenker, Y.2    Grekin, R.J.3    Vale, W.W.4
  • 31
    • 0030612281 scopus 로고    scopus 로고
    • Molecular pharmacology of somatostatin receptor subtypes
    • Patel YC 1997 Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 20:348-367
    • (1997) J Endocrinol Invest , vol.20 , pp. 348-367
    • Patel, Y.C.1
  • 32
    • 0036031864 scopus 로고    scopus 로고
    • Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line
    • Zatelli MC, Tagliati F, Piccin D, Taylor JE, Culler MD, Bondanelli M, degli Uberti EC 2002 Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. Biochem Biophys Res Commun 297:828-834
    • (2002) Biochem Biophys Res Commun , vol.297 , pp. 828-834
    • Zatelli, M.C.1    Tagliati, F.2    Piccin, D.3    Taylor, J.E.4    Culler, M.D.5    Bondanelli, M.6    degli Uberti, E.C.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.